$725.72 4.2%
LLY Stock Price vs. AI Score
Data gathered: January 20

AI Score



Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

AI Stock Analysis - Eli Lilly and Company (LLY)

Analysis generated January 4, 2025. Powered by Chat GPT.

Eli Lilly and Company (NYSE: LLY) is a leading pharmaceutical company known for its innovation in healthcare solutions. Established in 1876, Eli Lilly has a rich history of developing life-changing medications, including drugs for diabetes, cancer, and autoimmune diseases. With a strong focus on research and development, Eli Lilly has consistently delivered new treatments that address critical health challenges globally. The company operates in numerous segments including human pharmaceuticals and animal health, serving markets worldwide.

Read full AI stock Analysis

Stock Alerts - Eli Lilly and Company (LLY)

company logo Eli Lilly and Company | January 18
Reddit mentions are up by 166% in the last 24h.
company logo Eli Lilly and Company | January 15
AI Score is up by 27.1% in the last couple of days.
company logo Eli Lilly and Company | January 15
Reddit mentions are up by 180% in the last 24h.
company logo Eli Lilly and Company | January 15
Josh Gottheimer (member of U.S. congress) is selling shares

About Eli Lilly and Company

Eli Lilly and Co is a pharmaceutical company with a focus on neuroscience, endocrinology, oncology, and immunology. It discovers, develops, manufactures, and sells human pharmaceutical products and animal health products.


Eli Lilly and Company
Price $725.72
Target Price Sign up
Volume 5,460,000
Market Cap $653B
Year Range $725.72 - $958.35
Dividend Yield 0.83%
PE Ratio 78.12
Analyst Rating 88% buy
Earnings Date February 6 '25
Industry Drug Manufacturers

In the news


Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q3 '2411.4B4.24B7.2B970M2.25B1.180
Q2 '2411.3B4.61B6.69B2.97B4.12B3.920
Q1 '248.77B3.51B5.26B2.24B3.12B2.580
Q4 '239.35B4.17B5.18B2.19B3.03B2.490
Q3 '239.5B3.55B5.95B-57M6.4B0.100

Insider Transactions View All

Zakrowski Donald A filed to sell 5,480 shares at $803.4.
November 8 '24
LILLY ENDOWMENT INC filed to sell 96,891,978 shares at $969.2.
September 4 '24
LILLY ENDOWMENT INC filed to sell 96,892,957 shares at $968.3.
September 4 '24
LILLY ENDOWMENT INC filed to sell 96,894,557 shares at $967.3.
September 4 '24
LILLY ENDOWMENT INC filed to sell 96,899,877 shares at $966.2.
September 4 '24

Congress Trading View All

Politician Filing Date Type Size
Josh Gottheimer
Jan 15, 25 Sell $1K - $15K
Josh Gottheimer
Jan 15, 25 Sell $1K - $15K
Josh Gottheimer
Jan 15, 25 Sell $1K - $15K

What is the Market Cap of Eli Lilly and Company?

The Market Cap of Eli Lilly and Company is $653B.

What is Eli Lilly and Company's PE Ratio?

As of today, Eli Lilly and Company's PE (Price to Earnings) ratio is 78.12.

When does Eli Lilly and Company report earnings?

Eli Lilly and Company will report its next earnings on February 6 '25.

What is the current stock price of Eli Lilly and Company?

Currently, the price of one share of Eli Lilly and Company stock is $725.72.

How can I analyze the LLY stock price chart for investment decisions?

The LLY stock price chart above provides a comprehensive visual representation of Eli Lilly and Company's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Eli Lilly and Company shares. Our platform offers an up-to-date LLY stock price chart, along with technical data analysis and alternative data insights.

Does LLY offer dividends to its shareholders?

Yes, Eli Lilly and Company (LLY) offers dividends to its shareholders, with a dividend yield of 0.83%. This dividend yield represents Eli Lilly and Company's commitment to providing value to its shareholders through both potential capital appreciation and steady income. Investors considering Eli Lilly and Company in their portfolio should factor in this dividend policy alongside the company's growth prospects and market position.

What are some of the similar stocks of Eli Lilly and Company?

Some of the similar stocks of Eli Lilly and Company are Johnson & Johnson, Pfizer, Astrazeneca, AbbVie, and TherapeuticsMD.

.
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2025 AltIndex. All rights reserved.